Voleon Capital Management LP Pliant Therapeutics, Inc. Transaction History
Voleon Capital Management LP
- $4.09 Trillion
- Q3 2025
A detailed history of Voleon Capital Management LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Voleon Capital Management LP holds 149,041 shares of PLRX stock, worth $257,840. This represents 0.01% of its overall portfolio holdings.
Number of Shares
149,041Holding current value
$257,840% of portfolio
0.01%About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $84.2M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...